Skip to content
value.today

Ritter Pharmaceuticals Inc.

🇺🇸 Los Angeles, California, USABiotechnologyFounded 2008
Total raised
$12 M
3 rounds on record
Latest round
$4 M
Dec 2014
First round on record
Aug 2009
Today
Went public
See the company page

Ritter Pharmaceuticals Inc. is listed today as FF EAI Robotics Ecosystem Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Ritter Pharmaceuticals Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$5 MPrivate placement after listing$2 to $10 million

Ritter Pharmaceuticals Inc.: Private sale, Jul 2025

Investors in this round

14 investors had bought by the notice of Aug 13, 2025: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Ritter Pharmaceuticals Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Convertible Preferred Stock can convert to underlying shares of Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Campbell Becher · Executive Officer, Director
  • Braeden Lichti · Director
  • Cody B. Price · Director
  • Kevin Richardson II · Director
  • Robert B. Lim · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Univest Securities LLC (CRD 000036105) · New York, New YorkSold in AZ, MN, NE, NV, NY, UT

Remarks in the notice

  • On fees: “No sales commission or finder's fees”

Signed by Kevin Richardson II, Interim Chief Executive Officer and Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 13, 2025. Read the notice at the SEC.

equitySEC
Nov 2024$5 MPrivate placement after listing$2 to $10 million

Ritter Pharmaceuticals Inc.: Private sale, Nov 2024

Investors in this round

33 investors had bought by the notice of Nov 22, 2024.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Ritter Pharmaceuticals Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$408,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin Richardson II · Executive Officer · Interim Chief Executive Officer and Chief Financial Officer
  • Braeden Lichti · Director
  • Campbell Becher · Director
  • Cody Price · Director
  • Graydon Bensler · Director
  • Robert Lim · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Univest Securities LLC (CRD 000036105) · New York, New YorkSold in CA, CO, CT, DE, FL, IL, NE, NJ, NV, NY, PA, and outside the US

Signed by Kevin Richardson II, Interim Chief Executive Officer and Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 22, 2024. Read the notice at the SEC.

equitySEC
Nov 2018$6 MPrivate placement after listing$2 to $10 million

Ritter Pharmaceuticals Inc.: Private sale, Nov 2018

Investors in this round

11 investors had bought by the notice of Nov 9, 2018: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Ritter Pharmaceuticals Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$1,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$367,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew J. Ritter · Executive Officer, Director
  • Ira E. Ritter · Executive Officer, Director
  • John W. Beck · Executive Officer
  • Matthew W. Foehr · Director
  • Michael D. Step · Director
  • Noah E. Doyle · Director
  • Paul V. Maier · Director
  • William M. Merino · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • A.G.P./Alliance Global Partners (CRD 8361) · Westport, ConnecticutSold in all US states

Remarks in the notice

  • On fees: “7% of aggregate gross proceeds raised (less $750,000 paid by one Purchaser)”

Signed by Andrew J. Ritter, President. Source: SEC Form D, newest notice filed Nov 9, 2018. Read the notice at the SEC.

equity, optionsSEC
Dec 2014$4 MNo. 3$2 to $10 million

Ritter Pharmaceuticals Inc.: Raise no. 3, Dec 2014

Investors in this round

4 investors had bought by the notice of Dec 16, 2014: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Ritter Pharmaceuticals Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $6 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew J. Ritter · Executive Officer, Director
  • Ira E. Ritter · Executive Officer, Director
  • Michael D. Step · Executive Officer, Director
  • Noah E. Doyle · Director
  • Thomas E. Adamek · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew J. Ritter, President. Source: SEC Form D, newest notice filed Dec 16, 2014. Read the notice at the SEC.

equity, optionsSEC
Nov 2010$7 MNo. 2$2 to $10 million

Ritter Pharmaceuticals Inc.: Raise no. 2, Nov 2010

Investors in this round

16 investors had bought by the notice of Nov 22, 2013: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Ritter Pharmaceuticals Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew J. Ritter · Executive Officer, Director
  • Ira J. Ritter · Executive Officer, Director
  • Mike J. Step · Director
  • Noah J. Doyle · Director
  • Steven J. Markowitz · Director
  • Thomas J. Adamek · Director
  • Lee J. Williams · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Ritter, President. Source: SEC Form D and 2 amendments, newest notice filed Nov 22, 2013. Read the notice at the SEC.

equitySEC
Aug 2009$1 MNo. 1Under $2 million

Ritter Pharmaceuticals Inc.: Raise no. 1, Aug 2009

Investors in this round

1 investor had bought by the notice of Aug 17, 2009: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Ritter Pharmaceuticals Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1,000,000
What was sold
equity
Exemption claimed
  • Rule 505: the former limited-offering exemption (withdrawn in 2017)
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Ritter · Executive Officer, Director
  • Ira Ritter · Executive Officer, Director
  • Noah Doyle · Director
  • Steven Markowitz · Director
  • Lee Williams · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Ritter, President. Source: SEC Form D, newest notice filed Aug 17, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ritter Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2025

That is all the official record says: Ritter Pharmaceuticals Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Ritter Pharmaceuticals Inc. are on record.

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in Ritter Pharmaceuticals Inc.
InvestorKindAmountRoundRoleSource
Faraday Future Intelligent Electric Inc.Companynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Javelin Venture Partners I SPV I, LLCVenture capitalnot statednot statedHeld preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Javelin Venture Partners, L.P.Venture capitalnot statednot statedHeld preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Jiawei WangPersonnot statednot statedHeld Series B preferred stock (Form 3, 2025)SEC Form 3
Stonehenge Partners LLCFund or asset managernot statednot statedHeld preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 16 investors.

Largest shareholders today

Institutions holding FF EAI Robotics Ecosystem Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ritter Pharmaceuticals Inc.
NameRoleNamed in
Campbell BecherExecutive officerAug 2025
Kevin Richardson IIInterim Chief Executive Officer and Chief Financial OfficerNov 2024
Andrew J. RitterExecutive officerNov 2018
Ira E. RitterExecutive officerNov 2018
John W. BeckExecutive officerNov 2018
Michael D. StepExecutive officerDec 2014
Ira J. RitterExecutive officerNov 2013
Andrew RitterExecutive officerNov 2010
Ira RitterExecutive officerNov 2010
Braeden LichtiDirectorAug 2025
Campbell BecherDirectorAug 2025
Cody B. PriceDirectorAug 2025
Kevin Richardson IIDirectorAug 2025
Robert B. LimDirectorAug 2025
Cody PriceDirectorNov 2024
Graydon BenslerDirectorNov 2024
Robert LimDirectorNov 2024
Andrew J. RitterDirectorNov 2018
Ira E. RitterDirectorNov 2018
Matthew W. FoehrDirectorNov 2018
Michael D. StepDirectorNov 2018
Noah E. DoyleDirectorNov 2018
Paul V. MaierDirectorNov 2018
William M. MerinoDirectorNov 2018
Thomas E. AdamekDirectorDec 2014
Ira J. RitterDirectorNov 2013
Mike J. StepDirectorNov 2013
Noah J. DoyleDirectorNov 2013
Steven J. MarkowitzDirectorNov 2013
Thomas J. AdamekDirectorNov 2013
Andrew RitterDirectorNov 2010
Ira RitterDirectorNov 2010
Noah DoyleDirectorNov 2010
Steven MarkowitzDirectorNov 2010
Lee J. WilliamsPromoterNov 2013
Lee WilliamsPromoterNov 2010

Went public since 2016. Its SEC number is that of a company listed on a stock exchange.